Analgesics in Canada

After a spike in current retail value growth in 2020, systemic analgesics is expected to record more moderate growth in 2021. This is reflective of the way in which Canadians used analgesics during the COVID-19 pandemic for a wide variety of purposes, including core pain relief, symptomatic relief (particularly among elderly Canadians) and pain management while waiting for nonurgent, elective surgery, which was postponed as hospitals prioritised COVID-19 cases.

The publisher's Analgesics in Canada report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage:

Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage:

Market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Analgesics market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.